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ABSTRACT
The HpaR-mediated regulation of the hpa-meta
operon (Pg promoter) of the 4-hydroxyphenylacetic
acid catabolic pathway of Escherichia coli has been
studied. The HpaR regulator was puri®ed to homo-
geneity showing that it is able to bind selectively to
4-hydroxyphenylacetic, 3-hydroxyphenylacetic and
3,4-dihydroxyphenylacetic acids, which act as
inducers of the system. The role of HpaR as a
repressor and the requirement for cAMP receptor
protein for maximal activity have been con®rmed by
in vitro transcription analyses. Two DNA operators,
OPR1 and OPR2, have been identi®ed in the inter-
genic region located between the hpa-meta operon
and the hpaR gene. The OPR1 operator contains a
perfect palindromic sequence overlapping the tran-
scriptional +1 start site of the Pg promoter. The
OPR2 operator shows a similar but imperfect palin-
dromic sequence and is located far downstream of
the +1 start site of the Pr promoter. The binding of
HpaR to OPR2 displays a clear cooperativity with
OPR1 binding. Based on the above observations
and the results of permanganate footprinting experi-
ments, a repression mechanism for HpaR is postu-
lated. A 3-dimensional model of HpaR, generated by
comparison with the crystal structures of the homo-
logous regulators, MarR and MexR, suggests that
HpaR is a dimer that contains a typical winged-helix
DNA binding motif in each subunit.
INTRODUCTION
The hpa cluster of Escherichia coli W codes for a group of
proteins involved in the catabolism of 4-hydroxyphenylacetic
acid (4HPA) (1) (Fig. 1). The hpa catabolic genes are
organized in two operons: the upper operon (hpaBC) encoding
the two-component 4HPA monooxygenase, which transforms
4HPA to 3,4-dihydroxyphenylacetic acid (3,4HPA) (2,3), and
the meta operon (hpaGEDFHI) encoding the enzymes that
cleave the aromatic ring of 3,4HPA and allows its complete
mineralization (1,4). The hpa pathway is regulated by two
proteins named HpaA and HpaR (1). Although the role of the
HpaA activator of the hpaBC operon has been analyzed in
some detail (5), very few data are available on the function of
HpaR, the putative regulator of the hpa-meta operon (6). It has
been suggested that transcription of the homologous hpc-meta
operon of E.coli C is repressed by the product of hpcR (4) and
we have postulated that the homologous hpaR gene of E.coli
W might play a similar role (1,6). Recently, we have
demonstrated that the transcription from the Pg promoter of
the hpa-meta operon is strictly controlled by a global
regulatory system, which allows the expression of the hpa
catabolic genes only in the absence of a preferred carbon
source (6). This unusually strong catabolite repression control
of the Pg promoter of the hpa-meta operon is mediated by the
cAMP receptor protein (CRP). When E.coli W cells are grown
on glucose plus 4HPA, Pg is only active in stationary phase
and the activation mechanism requires the global regulator
integration host factor (IHF) (6) (Fig. 1).
In this work we have used different genetic and biochemical
approaches to characterize the interaction of HpaR with its
target DNA and its cognate inducer molecules. We have also
demonstrated that hpaR controls both the expression of the
hpa-meta operon (Pg promoter) and its own expression
(Pr promoter) through an unusual repression mechanism,
suggesting that although HpaR is related in amino acid
sequence and structure to the MarR family of regulators (7,8),
it is not related in its mode of action.
MATERIALS AND METHODS
Bacterial strains, plasmids and growth conditions
Bacteria were grown in LB medium (9) or M63 minimal
medium (10) at 30°C supplemented with thiamine (1 mg/ml)
and vitamin B12 (1 mg/ml) and 20 mM glycerol as carbon
source as described previously (6). When required, 1 mM
appropriate aromatic compound was added to the medium.
The aromatic compounds used as putative inducers were
purchased from Sigma. The abbreviations used are: 4HPA,
4-hydroxyphenylacetic acid; 3,4HPA, 3,4-dihydroxyphenyla-
cetic acid; 2HPA, 2-hydroxyphenylacetic acid; 3HPA,
3-hydroxyphenylacetic acid; PP, phenylpropionic acid; PA,
phenylacetic acid; 2,5HPA, homogentisic acid. When needed,
antibiotics were added at the following concentrations:
ampicillin, 100 mg/ml; tetracycline, 10 mg/ml; kanamycin,
50 mg/ml; rifampicin, 50 mg/ml. The E.coli strains and
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plasmids used in this work are listed in Table 1. The
pUTminiTn5 derivatives are mini-Tn5 delivery plasmids
used for the insertion of genes into the chromosome of
different E.coli strains by the ®lter-mating technique using
E.coli S17-1lpir as donor according to the method described
previously (15).
DNA manipulations and sequencing
Isolation of plasmid DNA, digestion with restriction enzymes,
ligation with T4 DNA ligase and transformation were carried
out as described elsewhere (9). DNA fragments were puri®ed
using the Geneclean Turbo Kit (BIO101 Inc.). Oligo-
nucleotides were synthesized in an Oligo-1000M nucleotide
synthesizer (Beckman Instruments). Nucleotide sequences
were determined directly from plasmids by using the dideoxy
chain termination method (9). The manufacturer's standard
protocols for Taq DNA polymerase-initiated cycle sequencing
reactions with ¯uorescently labeled dideoxynucleotide ter-
minators (Applied Biosystems Inc.) were used.
Construction of strains harboring a translational
Pr::lacZ fusion in the chromosome
To construct a translational fusion of the Pr promoter region of
hpaR and the lacZ reporter gene, a 314 bp DNA fragment
covering this promoter region was ampli®ed by PCR using 10
ng of plasmid pAJ40 (Table 1) as template and the primers
PAR3¢ (5¢-GCACGGATCCGTAATAGAAAAGGGGAC-3¢;
an engineered BamHI site is underlined) and PAR5¢ (5¢-
CCGAATTCCTTTCATGGTACCACTCC-3¢; the start codon
is indicated in bold and an engineered EcoRI site is
underlined). To create plasmid pBM2 (Table 1), the PCR
ampli®ed fragment was cut with EcoRI and BamHI endo-
nucleases and ligated to the EcoRI and BamHI double-
digested promoterless lacZ vector pUJ9 (Table 1). The correct
fusion was veri®ed by sequence analysis. Plasmids pPR13 and
pPR14 were constructed by subcloning the NotI cassette of
pBM2 into the mini-Tn5 delivery plasmids pUTminiTn5-Km
and pUTminiTn5-Tc, respectively (Table 1), and they were
used for insertion of the Pr::lacZ fusion into the chromosome
of E.coli AF15 and AFMC (Table 1), respectively, by the
®lter-mating technique (15). The generated exconjugants
containing the lacZ translational fusions inserted into their
chromosomes were selected for the transposon marker,
kanamycin, on rifampicin-containing LB medium to give the
strain WPR13 and selected on tetracycline-containing LB
medium for MCR14. In each case the ®nal strain was selected
from among three different exconjugants with similar expres-
sion levels and expression pro®les of the reporter gene. The
relevant genotypes of the resulting strains are indicated in
Table 1.
Overexpression and puri®cation of HpaR
The hpaR coding sequence was ampli®ed by PCR using
oligonucleotides HpaR5¢ (5¢-GGGAATTCTAAATGAAGG-
AGAAAGATAATGCACGACTC-3¢; the start codon is indi-
cated in bold and an engineered EcoRI site is underlined) and
HpaR3¢ (5¢-GGGTACCAAGCTTAGATACTAAAAAGTT-
ATTC-3¢; an engineered KpnI site is underlined) and plasmid
pAJ40 (Table 1) as DNA template. The ampli®ed DNA
fragment was digested with EcoRI and KpnI and then inserted
Figure 1. Regulation of the hpa cluster and sequence of the hpaR-hpaG intergenic region. The organization of the catabolic (hpaBCDEFGHI) transport
(hpaX) and the regulatory genes (hpaA and hpaR) of the hpa cluster, and their regulation by HpaA and HpaR and the global regulators CRP and IHF are
represented. The open arrows indicate the directions of gene transcription. PR, PG, PX, PA and PBC are promoter regions. The white square indicates the active
form of HpaR repressor; the black diamond indicates the inactive form of HpaA activator; the white circle represents the inducer. The lines ending in arrows
or bars indicate positive or negative effects, respectively. The complete nucleotide sequence of the hpaR-hpaG intergenic region (PR-PG probe) is indicated.
DNA regions located between triangles correspond to PG probe from ±80 to +46 (®lled triangles) and PR probe from ±216 to ±87 (empty triangles) numbered
relative to the Pg transcription start, taken as +1. The ±35 and ±10 boxes of the Pg and Pr promoters, the ribosome binding sites (RBS), the transcription start
site of Pg and Pr (+1) and the CRP and IHF sites are indicated. ATG start codons of hpaR and hpaG are shown in italic. ± and + indicate transcriptional
repression and activation, respectively. The OPR1 and OPR2 operators are indicated as dotted boxes.
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into vector pUC18Not (Table 1) under control of the Plac
promoter. The resulting recombinant plasmid pUCR1 was
transformed into E.coli MC4100 (Table 1). Escherichia coli
MC4100 (pUCR1) cells overproduced a 17 kDa protein (17%
of total protein) that corresponded to the expected size of
HpaR (Fig. 2).
To purify HpaR, E.coli MC4100 (pUCR1) cells cultured
overnight at 37°C in 500 ml of ampicillin-containing LB
medium were harvested by centrifugation, washed with saline
solution (0.9% NaCl) and, ®nally, resuspended in 25 ml of
HpaR buffer (20 mM Tris±HCl pH 7.5, containing 10%
glycerol, 2 mM b-mercaptoethanol, 1 mM EDTA and 100 mM
KCl). All the steps were performed at 4°C. Cells were lysed by
passage through a French press (Aminco Corp.) operated at a
pressure of 20 000 p.s.i. The crude extract was spun in an
ultracentrifuge at 150 000 g for 45 min and the supernatant,
which contains the soluble HpaR, was collected. Nucleic acids
present in the supernatant were removed by precipitation with
0.5% polyethyleneimine at pH 8.0. The solution was stirred
gently over 15 min followed by centrifugation at 18 000 g for
15 min. Then, the DNA free supernatant was dialyzed for
several hours against several changes of HpaR buffer (total
volume 5 l). After dialysis the protein solution becomes
cloudy due to the precipitation of a complex between HpaR
and traces of remaining polyethyleneimine. The precipitate
was recovered by centrifugation (18 000 g for 15 min) and
solubilized in 30 ml of HpaR buffer supplemented with KCl to
a concentration of 1 M. To eliminate the traces of
polyethyleneimine, the solubilized material was loaded onto
a phosphocellulose P11 (Whatman) column (10 ml),
equilibrated with the same buffer. In these conditions
polyethyleneimine binds to the column while HpaR does
not. Thus, the eluted unbound fraction, containing a
polyethyleneimine-free protein of 17 kDa that corresponded
to HpaR, was dialyzed against HpaR buffer. The purity of
HpaR was estimated by SDS±PAGE and Coomassie staining
(17). Using this procedure we obtained 2 mg of puri®ed HpaR
at a concentration of 0.2 mg/ml (Fig. 2). Further attempts to
concentrate HpaR were unfruitful due to its low solubility.
Phenyl-Sepharose chromatography
The DNA-free solution containing the HpaR protein was
added to 8 ml of phenyl-Sepharose CL-4B (Amersham-
Pharmacia Biotech AB) previously equilibrated with HpaR
buffer plus 1 M KCl. Then, the matrix was washed with 24 ml
of the same buffer without KCl to elute most of the retained
proteins. After this washing step, HpaR remained adsorbed to
the matrix by a speci®c interaction with the phenyl group. To
determine the compounds that could compete with the phenyl
group of the matrix releasing the HpaR protein, the washed
matrix containing the HpaR protein was eluted with different
solutions of 100 mM Tris±HCl pH 7.5 buffer containing one of
the putative competing compounds (4HPA, 2HPA, 3HPA,
3,4HPA, PP, PA, 3-hydroxycinnamic acid or 2,5HPA) at a
®nal concentration of 0.2 M. The corresponding eluted
fractions were analyzed by SDS±PAGE and Coomassie
staining.
Gel retardation assays (EMSA)
The DNA fragments PR-PG, PR and PG of 314, 179 and
147 bp, respectively, used as probes were ampli®ed by PCR
using 10 ng of plasmid pAJ40 (Table 1) as template and the
Table 1. Bacterial strains and plasmids
Strain or plasmid Revelant genotype or phenotype Reference
Escherichia coli K-12
S17-1lpir Host for pUT-derived plasmids (11)
MC4100 F± araD319 D(argF-lac)U169 relA1¯bB5301 deoC1 ptsF25 rbsR (5)
AFMC MC4100 Rifr (12)
MCR14 AFMC derivative, Pr::lacZ, Tcr This work
MCR141 MCR14 derivative, Pr::lacZ, hpa complete pathway, Kmr, Tcr This work
MCR142 MCR14 derivative, Pr::lacZ, Pr::hpaR, Kmr, Tcr This work
Escherichia coli W
W14 W derivative (Dpaa) (13)
AF15 W14 derivative (DlacZ), Rifr (12)
WPG11 W14 derivative (DlacZ, Pg::lacZ), Kmr (6)
WPR13 W14 derivative (DlacZ, Pr::lacZ), Kmr This work
Plasmids
pUJ9 Promoterless lacZ vector, Apr (14)
pAJ40 pUC18 derivative containing hpa pathway (1)
pHCR2 pACYC184 derivative with an EcoRI DNA fragment containing hpaR (1)
pUTminiTn5-Km MiniTn5 delivery plasmid, Kmr, Apr (14)
pUTminiTn5-Tc MiniTn5 delivery plasmid, Tcr, Apr (14)
pUC18Not Identical to pUC18 but with NotI sites ¯anking MCS (15)
pUCR1 pUC18Not derivative overexpressing the hpaR gene under Plac This work
pJCD01 pUC19 derivative, vector for in vitro transcription (16)
pBF1 pJCD01 derivative containing Pr-Pg promoters This work
pBM2 pUJ9 derivative, Pr::lacZ, Apr This work
pPR13 pUTminiTn5-Km derivative, Pr::lacZ, Kmr, Apr This work
pPR14 pUTminiTn5-Tc derivative, Pr::lacZ, Tcr, Apr This work
pAJ402 pUTminiTn5-Km derivative containing hpa pathway (1)
pBA1 pUCNot derivative, Pr::hpaR, Kmr, Apr This work
pBA2 pUTminiTn5-Km derivative, Pr::hpaR, Kmr, Apr This work
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CCACTCCTCGGATTCGATC-3¢) and PGDE (5¢-CCGG-
AATTCTGTAAATAGTTTGTTAATTAG-3¢) for the PG
fragment; PG5¢ (5¢-AACGCAAGAATTCGTGAGTCGTGC-
ATTATCTTTCCCC-3¢) and PRDE (5¢-CCGGAATTC-
GATAAGAATATATTAAATATC-3¢) for the PR fragment.
The DNA fragments were labeled at the 5¢-end with phage T4
DNA polynucletotide kinase and [g-32P]ATP (3000 Ci/mmol)
(Amersham Pharmacia Biotech). These fragments were puri-
®ed on a glass®ber column (High Pure PCR puri®cation kit;
Roche). Complexes with the labeled promoter region were
formed for 20 min at room temperature in 10 ml of buffer A
(40 mM HEPES pH 8.0, 10 mM magnesium chloride, 100 mM
potassium glutamate and 500 mg/ml bovine serum albumin)
using puri®ed HpaR protein. The mixture was loaded into a
7.5% native polyacrylamide gel. The gel was ®xed and dried
before being quanti®ed using a phosphorimager (Molecular
Dynamics).
KMnO4 and DNase I footprinting
Activators (100 nM CRP or IHF), prepared as described (6),
repressor HpaR (100 nM) and RNA polymerase (RNAp)
(100 nM), prepared as described (16), were allowed to form
complexes with the radioactively labeled PR-PG fragment for
20 min at 37°C in 15 ml of buffer A. In one set of experiments
2.5 ml of DNase I solution (1 mg/ml in 10 mM Tris±HCl,
10 mM magnesium chloride, 10 mM calcium chloride,
125 mM potassium chloride) were added and incubated at
37°C for 20 s, or for 30 s when RNAp was present in the
mixture. The reaction was stopped by addition of 200 ml of a
solution containing 0.4 M sodium acetate, 2.5 mM EDTA and
50 mg/ml calf thymus DNA, and put on ice. In the other set,
2.5 ml of KMnO4 solution (40 mM) was added to the
complexes for 30 s at 37°C. The reaction was stopped by
adding 2.5 mM 2-mercaptoethanol (2 M). Then all the samples
were phenol extracted and precipitated with ethanol. With the
KMnO4 samples, the ethanol precipitates were resuspended in
100 ml of piperidine (1 M), heated at 90°C for 30 min and
evaporated until dryness. Then 20 ml of water was added and
evaporated (twice). KMnO4 and DNase I samples were
resuspended in 5 ml of loading buffer (20 mM EDTA in
80% v/v formamide containing xylene cyanol blue and
bromophenol blue) and loaded on a 7% denaturing poly-
acrylamide gel.
Run-off transcription assays
Single round transcription by E.coli RNAp was carried out
under standard conditions (16), using buffer B (40 mM Tris±
HCl pH 8.0, 10 mM MgCl2, 100 mM KCl, 200 mM cAMP and
500 mg/ml acetylated bovine serum albumin) and supercoiled
DNA plasmid pBF1 (Table 1). To construct pBF1, the
oligonucleotides PG3¢ and PG5¢ (see above) were used for
PCR ampli®cation of the hpaR-hpaG intergenic region using
plasmid pAJ40 as DNA template. The ®nal volume of the
run-off reaction mixture was 9 ml, containing the plasmid
DNA (5 nM) with CRP (100 nM) and HpaR (100 nM) or
buffer. This mixture was incubated at room temperature for
20 min. Then, 3 ml of RNAp at 375 nM in buffer B was added
and the mixture was incubated at 37°C for 5 min in a ®nal
volume of 12 ml. Elongation was started by the addition of 3 ml
of a prewarmed mixture containing 1 mM ATP, 1 mM GTP,
1 mM CTP, 50 mM UTP, 1 mCi [a-32]UTP and 500 mg/ml
heparin in buffer B to the template±polymerase mix and
allowed to proceed for 5 min at 37°C. Reactions were stopped
by the addition of 12 ml of loading buffer (see above)
containing 1% SDS. After heating to 70°C, samples were
subjected to electrophoresis on 7% sequencing gels. Run-off
products were quanti®ed using a phosphorimager (Molecular
Dynamics).
Assay for b-galactosidase activity
Activities of the Pg and Pr promoters were monitored by
assaying b-galactosidase accumulation in cells harboring
either Pg::lacZ or Pr::lacZ fusions. Cells were grown in
M63 minimal medium and, when indicated, Pg and Pr
expression was induced with different aromatic compounds.
b-Galactosidase activity was measured as described by Miller
(10) and expressed in Miller units.
Primer extension
Primer extension analysis was used to determine the start site
of the transcription of hpaR. The reverse transcriptase AMV
primer extension system was used according to the protocol
supplied by the manufacturer (Promega). The primer used to
map the hpaR start site was R2+1 (5¢-GCAACGCAAT-
GGTTAGTGAG-3¢). Primer extension products were ana-
lyzed on a 6% polyacrylamide gel next to a sequence ladder
generated with the same primer. Sequencing reactions were
performed with Deaza G/A T7 Sequencing Mixes
(Pharmacia). RNA was prepared with a RNeasy Mini Kit
from E.coli MC4100 (pBM2) according to the protocol
supplied by the manufacturer (Qiagen).
Homology modeling of HpaR
The 3-dimensional structure of HpaR was modeled using
Swiss PDB Viewer 3.7 (18). The template used was MarR (8)
as a ligand-bound model. Raw structures obtained from ®tting
were subjected to steepest descent energy minimization. The
salicylate molecules were removed from the MarR-based
structure and substituted by 4HPA molecules by manual
docking using RASTOP 2.0.2. (http://www.genein®nity.org/
rastop/).
Figure 2. Overexpression and puri®cation of HpaR protein. SDS±PAGE
analysis of HpaR puri®cation from E.coli MC4100 (pUCR1) cells. Lane P,
the molecular mass markers in kDa; lane 1, soluble control extract from
E.coli MC4100 (pUC18Not); lane 2, soluble crude extract from E.coli
MC4100 (pUCR1); lane 3, supernatant after polyethylimine precipitation
and dialysis of crude extract from E.coli MC4100 (pUCR1); lane 4, puri®ed
HpaR protein by the method based on precipitation of HpaR under low
ionic strength conditions followed by phosphocellulose chromatography.
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In vitro and in vivo analysis of the HpaR ligands
At the time we were testing different chromatographic
supports to purify HpaR, we discovered that this protein
could be strongly and speci®cally retained on phenyl-
Sepharose due to its ability to interact with aromatic
compounds. This property allowed us to determine in vitro
the aromatic compounds that might act as ligands of HpaR.
Figure 3 shows that HpaR can be eluted from phenyl-
Sepharose by 4HPA, 3HPA and 3,4HPA. However, other
structurally related aromatic compounds, such as PP, PA,
2HPA, 2,5HPA and 3-hydroxycinnamic acid, were unable to
release HpaR from the phenyl-Sepharose support. These
results suggested that the interaction of HpaR with the phenyl
group of the matrix most likely takes place through the
effector recognition site of the protein, rather than by a non-
speci®c hydrophobic interaction. Moreover, they are in perfect
agreement with the observation that repression of the
hpc-meta operon of E.coli C caused by the homologous
HpcR regulator can be released in vivo by 4HPA, 3HPA or
3,4HPA (4).
To determine in vivo the range of HpaR inducers on the Pg
promoter of E.coli W, we used the reporter strain WPG11
(Pg::lacZ, hpa+) (Table 1). WPG11 was cultured for 2 h in
M63 minimal medium containing 20 mM glycerol and
different aromatic acids (1 mM) as inducers. Figure 3B
shows that the b-galactosidase activity was only increased in
the presence of 4HPA, 3HPA and 3,4HPA, corroborating the
hypothesis that these compounds are the prevalent and
primary inducers of the HpaR repressor. It is worth noting
that since WPG11 is a hpa+ strain, we could not at this stage
rule out the possibility that the effect of 3HPA and 4HPA
might be due to their transformation into 3,4HPA or into other
metabolites of the pathway. However, the observation that
these compounds speci®cally interact with HpaR in vitro as
well as the in vivo experiments performed on the homologous
HpcR regulator (4) support the idea that these compounds
could be true HpaR effectors (see also in vitro transcription
experiments below).
In vitro HpaR binding to the hpaG-hpaR intergenic
region
The ability of HpaR to bind to the hpaR-hpaG intergenic
region containing the Pg and Pr promoters (Fig. 1) was tested
in vitro by gel retardation assays (EMSA) (Fig. 4) using three
different DNA fragments as probes. While the PR-PG (Pg and
Pr promoters) fragment covers the entire DNA region located
between the hpaR genes and the hpa-meta operon, the PR
(Pr promoter) and PG (Pg promoter) fragments contain the
179 bp region upstream of hpaR and the 147 bp region
upstream of the hpa-meta operon, respectively (Fig. 1).
Remarkably, whereas two HpaR±DNA complexes were
detected with the PR-PG probe (complexes I and II), only
one was visible with each of the PG and PR probes (Fig. 4). To
localize the HpaR binding sites more precisely in the hpaR-
hpaG intergenic region, DNase I footprinting experiments
were performed using the PR-PG fragment as probe. These
experiments revealed that HpaR protects two operators,
named OPR1 (centered at position +2) and OPR2 (centered
at position ±199, relative to the transcription start site +1 of the
Pg promoter) (Figs 1 and 5). OPR1 and OPR2 both consist of a
27 bp region containing two inverted half-sites of 9 bp
separated by 4 bp (Fig. 5). These results are in agreement with
those presented above (Fig. 4) showing that one HpaR binding
site was located in the PG fragment (corresponding to OPR1)
and the other within the PR fragment (corresponding to
OPR2). In addition, EMSA experiments indicated that the
OPR1 site had an af®nity about 10-fold higher than the OPR2
site on the PR-PG fragment (Fig. 4A). Interestingly, when the
two operator sites are located on separate fragments, the
difference in their af®nities appeared much greater, reaching a
factor of 1000-fold, indicating that binding of HpaR to OPR2
on the PR-PG fragment is clearly cooperative with the binding
to OPR1 (Fig 4). Other experiments performed in the presence
of 4HPA on the PR-PG fragment revealed that the af®nity of
the Pg operator was only slightly decreased by the presence of
this compound (less than 2-fold) (data not shown).
Figure 3. Inducers of HpaR protein. (A) SDS±PAGE analysis of the
phenyl-Sepharose chromatography of HpaR. Lane P, molecular mass
markers shown in kDa; lanes 1±8, fractions eluted with 4HPA (lane 1),
2HPA (lane 2), 3HPA (lane 3), 3,4HPA (lane 4), PP (lane 5), PA (lane 6),
3-hydroxycinnamic acid (lane 7) and 2,5HPA (lane 8). (B) Effect of several
aromatic compounds on the expression of Pg promoter. Cells of E.coli
WPG11 (Pg::lacZ) were grown in glycerol-containing minimal medium in
the absence (no aromatic) or in the presence of 1 mM different aromatics
(4HPA, PA, 2HPA, 3HPA, PP, 2,5HPA, 3,4HPA and 3-hydroxycinnamic
acid) until the cultures reached an OD600 of 0.8. b-Galactosidase activities
were measured with permeabilized cells as described in Materials and
Methods.
6602 Nucleic Acids Research, 2003, Vol. 31, No. 22
 at Centro de Inform






In vitro transcription from the Pg promoter
Although we have demonstrated that 4HPA interacts with
HpaR in vitro and induces the hpa-meta operon in vivo, it was
only able to very slightly reduce the HpaR±DNA binding
af®nity in vitro according to the footprinting analysis (see
above). Thus, to ascertain the role of 4HPA in the induction of
HpaR-repressed Pg promoter, we developed an in vitro
transcription assay using plasmid pBF1 as DNA template.
Plasmid pBF1 contains the hpaR-hpaG intergenic region
¯anked by transcriptional terminators (Table 1). Since, as we
showed previously, the Pg promoter is CRP dependent (6), it
was not active when RNAp was the unique protein added to
the reaction mixture and, thus, only the RNA1 control
transcript is detected in the assay (Fig. 6). However, when
CRP was supplied to the previous reaction mixture, the Pg
activity was stimulated and a 139 nt transcript generated from
Pg was detected (Fig. 6). As expected, the addition of HpaR
clearly decreased the Pg transcription rate, demonstrating that
this protein was able to work in vitro as a repressor. Moreover,
the addition of 4HPA (Fig. 6), but not that of PA or 2HPA
(data not shown), restored the transcription activity of the
promoter. These results demonstrate, for the ®rst time,
repression by HpaR in vitro. But more importantly, it should
be noted that in these in vitro experiments 4HPA cannot be
transformed into other intermediates of the hpa catabolic
pathway, which could occur in the in vivo experiments shown
above and, therefore, these results con®rm unequivocally that
4HPA is a true inducer of the hpa-meta operon.
In¯uence of HpaR on open complex formation
To ascertain whether the repression mechanism mediated by
HpaR involves inhibition of the formation of the open
complex required for transcription initiation, we performed a
potassium permanganate footprinting assay using the PR-PG
fragment labeled at its Pg 5¢-end. Figure 7 shows that RNAp
alone induced only a weak reactivity of the thymine residues
from +2 to ±13, con®rming the fact that the Pg promoter is
inef®cient in the absence of its cognate activators, CRP and
IHF (6). Indeed, addition of CRP alone or a combination of
CRP and IHF (data not shown) signi®cantly increased open
complex formation at the Pg promoter. The presence of HpaR
abolished the permanganate reactivity of the thymine residues
characteristic of the Pg promoter, in agreement with its
inhibitory effect on Pg transcription. Although HpaR alone
did not induce any pattern of reactivity to permanganate or
open complex formation (Fig. 7), a new pattern of reactivity to
permanganate was detected from position ±22 to ±32, between
the ±10 and ±35 promoter boxes of the Pg promoter, just
upstream of the HpaR binding site, when HpaR, CRP and
RNAp were present in the same reaction mixture. This
suggests that HpaR does not prevent RNAp from binding to
the Pg promoter region but effectively blocks promoter escape
by displacing RNAp from its usual location (Fig. 7).
Regulation of the Pr promoter
To check whether expression of the divergently transcribed
Pr promoter, which drives expression of the hpaR gene
(Fig. 1), was also regulated by HpaR, we have engineered a
reporter Pr::lacZ translational fusion within plasmid pBM2
(Table 1). Firstly, the transcriptional start site of hpaR was
determined in plasmid pBM2 by primer extension (Fig. 8).
This experiment revealed that the transcription of hpaR starts
at a G residue located at position ±153 relative to the
transcriptional start site of the Pg promoter (Figs 1 and 8). A
putative ±10 box (TAAAAT) located 9 bp upstream of the
Pr +1 site and a putative ±35 box (TTAATA) with a spacer of
Figure 4. HpaR binding to the hpaR-hpaG intergenic region. EMSAs were performed as indicated in Materials and Methods. The DNA probes used were
(A) PR-PG and (B) PG and PR. Increasing concentrations of puri®ed HpaR were used. (A) Lane 1, 0 nM; lane 2, 3 nM; lane 3, 10 nM; lane 4, 30 nM; lane 5,
50 nM; lane 6, 75 nM; lane 7, 150 nM; lane 8, 300 nM. (B) Lanes 1 and 9, 0 nM; lane 2, 3 nM; lane 3, 10 nM; lane 4, 30 nM; lane 5, 50 nM; lane 6, 75 nM;
lane 7, 100 nM; lane 8, 200 nM; lane 10, 10 nM, lane 11, 30 nM; lane 12, 50 nM; lane 13, 75 nM; lane 14, 100 nM; lane 15, 200 nM; lane 16, 1000 nM.
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18 bp were identi®ed. As expected, these Pr promoter boxes
are similar to the typical boxes of s70-dependent promoters.
The Pr::lacZ translational fusion was subcloned in a mini-
Tn5 vector resulting in plasmids pPR13 and pPR14 (Table 1).
These plasmids were used to deliver, by transposition, the
Pr::lacZ fusion into the chromosomes of E.coli W AF15
(hpa+, DlacZ) and E.coli K12 AFMC (hpa±, DlacZ), generating
the reporter E.coli strains WPR13 (hpa+, Pr::lacZ) and
MCR14 (hpa±, Pr::lacZ), respectively. b-Galactosidase assays
performed with permeabilized E.coli WPR13 and E.coli
MCR14 cells cultured in the presence or absence of 1 mM
4HPA revealed a signi®cant effect of 4HPA on Pr expression
in the WPR13 strain (2.6-fold increase in b-galactosidase
activity), whereas Pr expression in the MCR14 strain was
constitutive (Table 2). These results showed that the Pr
promoter was regulated by a regulator of the hpa cluster, but
since we have demonstrated that this cluster contains two
regulators, HpaR and HpaA, that respond to 4HPA (5), they
did not allow us to determine if Pr expression was regulated
by HpaR or HpaA.
To establish the role of HpaR in Pr expression, the E.coli
strains S17-1lpir (pAJ402) and S17-1lpir (pBA2) (Fig. 9 and
Table 1) were used to transfer the hpaR gene into the
chromosome of E.coli MCR14, generating the exconjugants
MCR141 and MCR142, respectively. Table 2 shows that in
E.coli MCR141 and E.coli MCR142 Pr transcription
decreased 18-fold in the presence of the hpaR gene, strongly
suggesting that HpaR represses the Pr promoter. The presence
of 4HPA produced only a slight increase in b-galactosidase
activity in both strains. This result could be attributed to more
ef®cient synthesis of the HpaR protein in the heterologous
K12 strain than in the wild-type W strain.
Finally, the strain WPR13 was also used to determine in vivo
the range of HpaR inducers which act on its own Pr promoter.
As expected, b-galactosidase activity was only increased in
the presence of 4HPA, 3HPA and 3,4HPA, con®rming that
these compounds are also inducers of the HpaR repressor
when it regulates its own expression (Fig. 9).
Homology modeling of ligand-bound HpaR
Taking into account the sequence homology of HpaR with the
MarR regulator (19% identity, 45% similarity; Fig. 10A), we
have modeled the 3-dimensional structure of ligand-bound
HpaR using the crystal coordinates of this regulator (8)
(Fig. 10B and C). MarR is a dimer that contains a typical
winged-helix DNA binding motif in each monomer. The two
recognition helices are supposed to bind two adjacent major
grooves of DNA, whereas the wings might well be positioned
to make minor groove or phosphate backbone contacts to the
distal parts of the inverted repeat. However, up to now, no
structure of a DNA±protein complex is available for a protein
of the MarR family. Based on the MarR crystal, HpaR might
bind two molecules of 4HPA per monomer, one of them
between the DNA recognition helix and the `wing' structure
(corresponding to the SAL-A site in MarR) and the other
between the recognition helix and the a2 helix (corresponding
to the SAL-B site in MarR) (Fig. 10B and C). In both cases, the
ligands would be solvent exposed. A comparison of the
modeled 4HPA binding sites in HpaR with those of salicylate
in MarR reveals that their overall con®guration is retained in
Figure 5. DNase I footprinting analysis of the interaction of HpaR with the
Pr-Pg promoter region. The reaction mixture was treated as described in
Materials and Methods using as probe the 5¢-end-labeled non-coding strand
of the Pr-Pg region of the hpaGEDFHI operon showing (A) the OPR1 and
(B) the OPR2 protected regions. HpaR concentrations were as follows. (A)
Lane 1, 0 nM; lane 2, 10 nM; lane 3, 30 nM; lane 4, 100 nM; lane 5,
200 nM. (B) Lane 1, 0 nM; lane 2, 30 nM; lane 3, 100 nM; lane 4, 200 nM;
lane 5, 400 nM; lane 6, 1000 nM. An A+ G sequencing ladder is indicated
with an asterisk. (C) OPR1 and OPR2 operators. Operators are indicated
and conserved nucleotides are shown in bold. Arrows represent the inverted
repeat sequences.
Figure 6. In vitro transcription assay of the Pg promoter. Run-off transcrip-
tion from Pg. Single round in vitro transcription was carried out by using
the plasmid pBF1 as template. RNAp, CRP and HpaR were added at ®nal
concentrations of 100 nM each and the ®nal concentration of the inducer
4HPA was 10 mM. The Pg-derived mRNA (139 nt) and the vector-derived
RNA1 are indicated by arrows.
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HpaR, which is not surprising considering the similarity
of the salicylate and 4HPA structures. Moreover, the non-
conservative changes between the two sequences can be
explained in terms of the accommodation of the hydroxyl
group located in a different position in the aromatic ring of the
ligand. This, and the fact that no notable steric clashes are
produced in the model, support the reliability of the latter.
DISCUSSION
Based on sequence comparison analysis, the HpaR protein of
the hpa catabolic cluster from E.coli W had been proposed to
be a transcriptional regulator belonging to the MarR family,
but until now, there was no experimental evidence concerning
its function and properties (5,6). The activity of the MarR-like
proteins found in bacteria and archaea are modulated in
response to environmental signals and they play important
roles in global health problems caused by bacterial pathogens
since they control genes implicated in antibiotic resistance and
hemolysis (7,19). Some members of this family are involved
in speci®c responses to aromatic compounds, e.g. MarR
(7,20), CinR (21), HpcR (4,5), BadR (22) and EmrR (23).
Most of the regulators belonging to this family are transcrip-
tional repressors with the exception of BadR (22), CbaR (24),
SlyA (25) and NhhD (26), which function as activators.
Moreover, MexR can act as either a transcriptional repressor
or activator (27). Recently, the crystal structures of MarR and
MexR have been described (8,28) and these ®ndings have
increased the interest in these regulators since they have paved
the way for structural studies on other members of the family.
Remarkably, although many positive regulators have been
shown to control the aromatic catabolic pathways in bacteria,
only a few repressors have been described in these pathways
(19). The known repressors include the CymR regulator in the
catabolism of p-cimene in Pseudomonas putida F1 (29),
the AphS repressor of phenol catabolism in Comamonas
testosteroni TA441 (30,31) and the PaaX and PaaN regulators
of the PA catabolic pathway from E.coli (12) and P.putida U
(32), respectively. In this context it appeared very interesting
to perform the ®rst rigorous analysis of the HpaR repressor. In
this work, we have demonstrated that HpaR negatively
regulates not only expression of the hpa-meta operon but
also its own expression. The fact that HpaR can regulate its
own expression agrees with observations for other MarR-like
proteins (23,33) and may represent a common feature of this
family of regulators (21). In addition, we have illustrated
experimentally that HpaR binds speci®cally to both the Pg and
Pr promoter regions. The intrinsic binding af®nity for the
Pg operator (OPR1) was 100-fold higher than that for the
Pr operator (OPR2) when the operators were carried on
different fragments (Fig. 4B). Although HpaR bound coopera-
tively to both operators on the native PR-PG template, OPR1
remains the ®rst operator to be occupied by the HpaR
repressor. These data indicate that as soon as the inducers are
Figure 7. KMnO4 footprinting of the Pg promoter. (A) The reaction mixture
was treated as described in Materials and Methods using as probe the
5¢-end-labeled non-coding strand of the Pr-Pg region. RNAp, CRP and
HpaR were added at ®nal concentrations of 100 nM. The positions sensitive
to KMnO4 are indicated. An A+ G sequencing ladder is indicated with an
asterisk. (B) Nucleotide sequence of the Pg region showing the ±35 and
±10 promoter boxes and +1 site. The positions sensitive to KMnO4 corres-
ponding to the open complex (empty boxes) and to the HpaR-dependent
DNA bubble (hatched boxes) are indicated.
Figure 8. Mapping of the hpaR transcriptional start site by primer
extension. Total RNA was isolated from LB grown E.coli MC4100 (pBM2)
cells (lane 1). A sequence ladder generated with the same primer (R2+1) is
shown (lanes A, C, G and T). The position of the primer extension product
is indicated by the asterisk.
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depleted from the medium, HpaR binds to OPR1 to shut off
expression of the catabolic enzymes before HpaR starts to
inhibit its own expression by binding to OPR2. DNase I
footprinting (Fig. 5) revealed that OPR1 comprises a 27 bp
region containing a palindromic sequence of 9 bp on each side
separated by 4 bp (Fig. 5). A similar structural design has been
described for the operators of other promoters controlled by
MarR-like regulators (21,33). The DNA binding site of MarR
consists of a 21 bp sequence organized into an inverted repeat
(33) and CinR protects a DNA region of 16 bp showing similar
characteristics (21). All these ®ndings are consistent with the
dimeric structure proposed for MarR-like regulators where
each subunit binds to one of the two inverted half-sites of the
operator (8), and suggest an architecture conserved through
evolution.
The fact that OPR1 is centered at position +2 of Pg, i.e.
overlapping the transcriptional start site, suggests that HpaR
should repress transcription from Pg by a mechanism based on
steric hindrance, by inhibiting binding of RNAp to the
promoter. However, in the presence of both RNAp and HpaR a
new pattern of thymine residues reactive to permanganate
appears ~20 bp upstream of the cognate transcription bubble.
This result suggests that RNAp and the repressor are bound
simultaneously to the Pg promoter forming a ternary complex
that inhibits formation of the open complex around the
transcriptional start site. Taking into account the results of the
in vitro transcription assay (Fig. 6), HpaR might repress
transcription from Pg by generating an upstream displacement
of RNAp from its functional promoter binding site and hence
preventing transcription initiation by a road-block mechanism.
Although this sort of repression is not very frequent, there are,
in the literature, some examples of regulators that remain
bound to the promoter in the presence of RNAp, e.g. protein w
of the broad host range plasmid pSM19035 (34), the factor for
inversion stimulation of E.coli (Fis) at the bgl promoter (35),
TyrR in the aroP2 promoter of E.coli (36), Spo0A at the abrB
promoter of Bacillus subtillis (37) and Arc at the Pant
promoter of phage P22 (38). Therefore, HpaR could be
considered as a new representative of this type of regulator.
Footprinting analyses have demonstrated that a second
HpaR operator, OPR2, is centered at position +47 relative to
the Pr transcriptional start site (Fig. 5). The location of OPR2
with respect to the +1 site of Pr suggests that the repression
effect might be produced by inhibiting the transcription
elongation process. OPR2 comprises a 27 bp region with a
similar organization to OPR1. One of the half-sites of the
operator is identical to that of OPR1 but the other consists of
an imperfect repeat with four nucleotide changes (Fig. 5).
These differences could explain the lower binding af®nity of
HpaR to OPR2 when compared to OPR1. On the other hand,
we have observed that the binding to OPR2 is clearly
cooperative with the binding to OPR1. Since HpaR binding
experiments were performed in the absence of other DNA-
binding proteins, such as CRP or IHF, this cooperative effect
indicates that the binding of HpaR to OPR1 stabilizes its
binding to OPR2 by protein±protein interactions. Preliminary
experiments performed by analytical ultracentrifugation sug-
gest that HpaR is a dimer in the absence of effector (data not
shown). Nevertheless, we cannot eliminate the hypothesis of
Table 2. Repression of Pr promoter by HpaR
Strain b-galactosidase activity (Miller units)
±4HPA +4HPA
MCR14 (±HpaR, ±HpaA) 1544 1495
MCR141 (+HpaR, +HpaA) 87 119
MCR142 (+HpaR, ±HpaA) 72 109
WPR13 (+HpaR, +HpaA) 510 1350
Figure 9. Regulation of the Pr promoter. (A) Schematic construction of
E.coli MCR142 (Pr::hpaR, Pr::lacZ). (B) Effect of several aromatic
compounds on expression of the Pr promoter. Cells of E.coli WPR13
(Pr::lacZ) were grown in glycerol-containing minimal medium in the
absence (no aromatic) or in the presence of 1 mM different aromatics
(4HPA, PA, 2HPA, 3HPA, PP, 2,5HPA, 3,4HPA and 3-hydroxycinnamic
acid) until the cultures reached an OD600 of 0.8. b-Galactosidase activities
were measured with permeabilized cells as described in Materials and
Methods.
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dimerization (or oligomerization) of the HpaR dimers to
explain the striking cooperativity observed in HpaR binding to
OPR1 and OPR2. Two dimers of HpaR bound at OPR1 and
OPR2 could interact together leading to the formation of an
oligomer which could generate a repression loop. The distance
between the two operators is 200 bp, which corresponds to 19
turns of B-DNA helix (assuming a pitch of 10.5 bp per turn).
Hence, the two dimers of HpaR should be positioned on the
same face of the DNA helix. It is also likely that CRP and IHF
help to stabilize the repression loop by bending DNA, whereas
4HPA might disturb the interactions between two HpaR
dimers and HpaR±DNA complexes. A similar mechanism has
been proposed in the case of the gal promoter region where
both the presence of histone-like unstable nucleoid protein and
the supercoiled state of the template are required to close the
repression loop formed by dimerization of the gal repressor
dimers bound to each operator (39,40). Validation of this
hypothetical mechanism for HpaR repression requires further
research.
The in vivo experiments performed with E.coli WPR13
(Pr::lacZ, hpa+) and E.coli WPG11 (Pg::lacZ, hpa+) have
demonstrated that activation of the Pg and Pr promoters
requires the presence of 4HPA, 3HPA or 3,4HPA as inducer.
These results correlate with the observations obtained by
phenyl-Sepharose chromatography where HpaR appears to be
adsorbed to the matrix by a pseudo-af®nity mechanism. The
®nding that only the compounds 4HPA, 3HPA and 3,4HPA
were able to desorb the protein suggests that most likely the
interaction of HpaR with this matrix takes place through the
effector binding site of HpaR. However, it was surprising that
although these results clearly demonstrate that the inducers
interact directly with the protein, the presence of inducer even
at high concentration (10 mM) (Fig. 4) and in different ionic
strength conditions had little effect on HpaR binding. It
decreased HpaR af®nity for OPR1 by only 2-fold in DNase I
footprinting assays and had hardly any effect on HpaR binding
to DNA in EMSAs (data not shown). In this respect it has been
previously documented that under in vitro conditions some
repressors are not released from the DNA in the presence of
the effector (39). It could be argued that a correct response of
the HpaR±DNA interaction to the presence of the effector
requires the presence of RNAp located in close contact with
the OPR1±HpaR±4HPA complex in order to destabilize the
repressor complex by protein±protein interactions. Moreover,
the supercoiled structure of DNA might be necessary to
observe derepression. The latter argument correlates with our
observation that 4HPA was able to induce derepression in vitro
in the run-off transcription experiments when the template was
Figure 10. Model of ligand-bound HpaR structure. (A) Amino acid sequence alignment of the HpaR and MarR proteins. Residues corresponding to the
SAL-A type binding site are shown in bold. Residues corresponding to the SAL-B type binding site are represented in lower case. The putative HpaR DNA
recognition helix is boxed. Alignment was done with the BESTFIT program. (B) Detail of the `SAL-A' type 4HPA binding site. The ligand is depicted in
space®ll representation and interacting residues are shown in thick wireframe format. Note that 4HPA could also bind in an alternative orientation, rotated
180° around the z-axis. (C) Detail of the `SAL-B' type 4HPA binding site. The scheme representation is as indicated for (B).
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a supercoiled plasmid (Fig. 6B) and not a linear fragment (data
not shown).
Analysis of the 3-dimensional structures of MexR and
MarR regulators suggests that despite their similarities in
sequence and structure their regulatory mechanisms are
different (28). MexR recognizes an inverted repeat separated
by 5 bp, which facilitates binding of the two subunits to the
same face of the DNA, i.e. a single dimeric molecule can
interact with the operator. It has been proposed that MexR
regulates its DNA binding activity by shifting the distance
between the DNA binding helices of each monomer as a result
of a conformational change induced by interaction of the
effector with the C-terminal region of MexR (28). The case of
MarR protein is more puzzling since the two inverted repeat
half-sites on the DNA are separated by only 2 bp, a distance
unlikely to be able to accommodate the two recognition
helices in two adjacent major grooves of DNA. Moreover, in
the liganded protein complex, two arginine side chains known
to be involved in speci®c DNA binding (41) are predicted to
point away from the bases in the major groove. MarR binding
to the operator site as a single dimer would only take place
after a considerable rearrangement in both the spacing and the
orientation of the recognition helices that could require the
binding of a new effector. However, it still cannot be excluded
that two dimers of the MarR protein bind on different faces of
the DNA to each half-site. The recent structure of SlyA, a
member of the MarR family in the unligated state at 1.6 AÊ
resolution, does not shed more light on the mode of DNA
binding of these proteins (41).
The above considerations indicate that the members of the
MarR family of regulators may be diverse both in the types of
effector molecules recognized and in the ways their DNA
binding activity is regulated, and it appeared interesting to
analyze the case of HpaR. Taking into account that the two
inverted repeats in the HpaR operator are separated by 4 bp,
HpaR repression could likely be explained by the binding of a
single dimer to both repeats of the operator. The fact that
HpaR might bind to DNA both in the absence and in the
presence of 4HPA suggests that small changes in the
quaternary structure of the repressor should be the key event
for regulation, rather than binding itself. According to our 3-
dimensional model (data not shown), binding of 4HPA,
especially in the `SAL-B' type site, may substantially affect
the dimerization interface between the two monomers, leading
to a different positioning of the recognition helices.
The analysis of HpaR presented here represents the most
detailed characterization of a regulatory protein of an aromatic
catabolic pathway from E.coli and provides clear evidence
that the complex hpa regulatory system will provide new
insights in the ®eld of the regulation of secondary metabolic
pathways of this model microorganism.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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